Tg Therapeutics (TGTX) Net Equity Issued and Repurchased (2011 - 2023)
Tg Therapeutics' (TGTX) quarterly Net Equity Issued and Repurchased came in at -$1000.0 in Q4 2023, up 99.88% quarter-over-quarter from -$803000.0 in Q3 2023.
Tg Therapeutics (TGTX) Net Equity Issued and Repurchased (2011 - 2023) Analysis & Trends
Tg Therapeutics' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$1000.0 in Q4 2023; TTM through Dec 2024 was -$804000.0, a 104.9% decrease from a year earlier, with the FY2023 full-year figure at $46.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased climbed to -$1000.0 in Q4 2023 per TGTX's latest filing, from -$803000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at -$1000.0 in Q4 2023 and bottomed at -$803000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -803,000.00 |
| Sep 30, 2023 | -803,000.00 |
| Mar 31, 2014 | 17.22 Mn |
| Mar 31, 2014 | 17.22 Mn |
| Sep 30, 2013 | 37.65 Mn |
| Sep 30, 2013 | 37.65 Mn |
| Dec 31, 2011 | 9.79 Mn |
| Dec 31, 2011 | 9.79 Mn |
| Sep 30, 2011 | 30,115.00 |
| Sep 30, 2011 | 30,115.00 |